[ET Net News Agency, 18 March 2024] FRONTAGE (01521) fell 3.2% to HK$1.5.
It hits an intra-day low of HK$1.5, hitting a historical low, and an intra-day high of
HK$1.58. The total shares traded was 1.34 million, with a value of HK$2.06m. The active
buy/sell ratio is 24:76, with net selling turnover of HK$886,080. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$299,225, with volume weighted average
price of HK$1.54. FUTU SEC INT'L accounts for greatest net responsive selling turnover of
HK$119,715, with volume weighted average price of HK$1.535. The stock has fallen a
combined 10.2% over the past 2 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 1.500 % Chg -3.23%
High 1.580 Low 1.500
Shares Tr 1.34m Turnover 2.06m
10-D SMA 1.574 %H.V 50.335
20-D SMA 1.654 VWAP 1.534
50-D SMA 1.799 RSI14 36.221
--------------------------------
Status: Hitting a historical low, active buy/sell ratio is 24:76, with net selling
turnover of HK$886,080, falling a combined 10.2% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
FRONTAGE (01521) 1.50 -3.23
HUTCHMED (00013) 28.00 -0.36
GENSCRIPT BIO (01548) 16.92 -1.63
INNOVENT BIO (01801) 42.50 -0.35
EVEREST MED-B (01952) 26.60 +3.91
WUXI BIO (02269) 14.50 +0.42
TIGERMED (03347) 31.65 +0.32
BEIGENE (06160) 102.10 -1.83
SCICLONE PHARMA (06600) 15.32 +9.12
AKESO (09926) 51.45 -0.96
-----------------------------------------------
(ed)